Item 2.02 Results of Operation and Financial Condition

On May 4, 2021, CytoSorbents Corporation (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2021. A copy of the press release is furnished herewith as Exhibit 99.1.*





Item 9.01 Exhibits




(d) Exhibits




Exhibit No. Description

  99.1        Press Release of the Company, dated May 4, 2021

* The information in Item 2.02 of this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

© Edgar Online, source Glimpses